Lighthouse Genomics Inc. Expands Company IP Holdings, Prepares for Launch of Cannabis Authenticity and Purity Standard
August 25, 2020 08:00 ET
|
Lighthouse Genomics Inc.
VANCOUVER, British Columbia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Lighthouse Genomics Inc. (“Lighthouse” or the “Company”), announces filing a US patent application and Canadian trademark applications...
Aravive Announces Management Changes
January 09, 2020 16:05 ET
|
Aravive, Inc.
Rekha Hemrajani Appointed President, Chief Executive Officer and Director to Execute Corporate Strategy as Company Advances Clinical Pipeline Jay Shepard to Assume Role of Chairman of the Board of...
Orchard Therapeutics Further Strengthens Board of Directors with Appointment of John Curnutte, M.D., Ph.D.
August 30, 2019 08:00 ET
|
Orchard Therapeutics
BOSTON and LONDON, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with...
Adverum Biotechnologies Announces Board Changes
May 02, 2019 16:30 ET
|
Adverum Biotechnologies, Inc.
Independent Directors Rekha Hemrajani, James Scopa and Mark Lupher Added to the Board Patrick Machado Appointed as Board Chair; Paul Cleveland Retires from the Board MENLO PARK, Calif., May 02,...
Severe Acute Respiratory Syndrome (SARS) Infection Drug Pipeline Study, H2 2018 - Analysis of Phases, Companies, Mechansim, Trials, & Current Status of Pipeline Drugs
February 27, 2019 03:38 ET
|
Research and Markets
Dublin, Feb. 27, 2019 (GLOBE NEWSWIRE) -- The "Severe Acute Respiratory Syndrome (SARS) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status...
Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing
February 13, 2019 14:07 ET
|
3-V Biosciences
HANGZHOU, China and SHAOXING, China and SAN FRANCISCO, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Ascletis Pharma Inc. (Ascletis, 1672.HK) and 3-V Biosciences, Inc. (3-V Biosciences) jointly announce today...
Rhinovirus Infection Drug Pipeline Study, H2 2018 - Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs
January 28, 2019 11:35 ET
|
Research and Markets
Dublin, Jan. 28, 2019 (GLOBE NEWSWIRE) -- The "Rhinovirus Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for...
University of Notre Dame and Indiana Biosciences Research Institute partner to address health concerns
December 05, 2018 13:04 ET
|
Indiana Biosciences Research Institute
NOTRE DAME, Ind., Dec. 05, 2018 (GLOBE NEWSWIRE) -- The University of Notre Dame and the Indiana Biosciences Research Institute (IBRI) have signed a strategic alliance agreement to encourage...
EVIO Inc. Co-Founder, CEO and Chairman, William Waldrop Discusses Company Updates with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
August 27, 2018 08:00 ET
|
EVIO Labs, Inc.
PHOENIX, Ariz., Aug. 27, 2018 (GLOBE NEWSWIRE) -- EVIO Inc. (OTCQB:EVIO) (the “Company”) announced CEO, William Waldrop’s interview on Uptick Newswire’s “Stock Day” Podcast. Everett Jolly began the...
Cannabis Leaf (PCFP) Completes Merger with Apotheca Biosciences – Company’s R & D Focuses on Opioid Crisis, a National Public Health Emergency
June 25, 2018 07:30 ET
|
Apotheca Biosciences
Saint Petersburg, FL, June 25, 2018 (GLOBE NEWSWIRE) -- Cannabis Leaf (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, formulation and cannabis delivery technologies...